Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma.
The authors review the extensive literature on the asthmatic effects of Paf-acether (PAF), suggesting that anti-asthmatic drugs may owe their therapeutic efficacy to their inhibition of PAF-induced pathology.
D001249:Asthma / Q000503:physiopathology*; D004487:Edema / Q000503:physiopathology; D004804:Eosinophils / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D010972:Platelet Activating Factor / Q000502:physiology*
D010972:Platelet Activating Factor